Attached files

file filename
EX-21 - EX 21 LIST OF SUBSIDIARIES - BLONDER TONGUE LABORATORIES INCblonderex21to10k031711.htm
EX-31.2 - EX 31.2 CERTIFICATION - BLONDER TONGUE LABORATORIES INCblonderex312to10k031711.htm
EX-23.1 - EX 23.1 IND. REG. PUBLIC ACCOUNTING FIRM'S CONSENT - BLONDER TONGUE LABORATORIES INCblonderex231to10k031711.htm
EX-31.1 - EX 31.1 CERTIFICATION - BLONDER TONGUE LABORATORIES INCblonderex311to10k031711.htm
EX-10.19 - EX 10.19 2005 FORM OF OPTION AGREEMENT DIR PLAN - BLONDER TONGUE LABORATORIES INCblonderex1019to10k031711.htm
EX-10.18 - EX 10.18 2005 FORM OF OPTION AGREEMENT EE PLAN - BLONDER TONGUE LABORATORIES INCblonderex1018to10k031711.htm
10-K - BLONDER 10K 031711 - BLONDER TONGUE LABORATORIES INCblonder10k031711.htm
EX-10.23 - EX 10.23 DEFERRED COMPENSATION PLAN LUKSCH - BLONDER TONGUE LABORATORIES INCblonderex1021to10k031711.htm

EXHIBIT 32.1


CERTIFICATION PURSUANT TO
 
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 


To the knowledge of each of the undersigned, this Annual Report on Form 10-K for the year ended December 31, 2010 complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of Blonder Tongue Laboratories, Inc. for the applicable reporting period.
 


Date:  March 21, 2011                                                          By:           /s/  James A. Luksch 
James A. Luksch, Chief Executive Officer

By:           /s/  Eric Skolnik 
Eric Skolnik, Chief Financial Officer